Navigating climate-focused AI funding offers a unique milestone for turning research concepts into transformative tools. CEO Aaron Schacht describes how BiomEdit’s Bezos-funded “digital twin” work aims to model genetics, feed and microbiome to predict performance and methane reduction, creating a platform that could serve both producers and future commercial partners.

Harnessing the power of real-world evidence is critical to scaling precision medicine. Christina Lopes, Co-Founder & CEO of FidoCure, shares how the company built a canine cancer dataset and leveraged AI to transform data points into targeted therapies, driving adoption beyond oncology specialists and enabling validated and scalable solutions.

For emerging biotech companies, the right partnerships are pivotal to growth. Dr. Tony Sasse, Founder & Managing Director of Snoretox, shares how his team identified investors and collaborators who believed in their mission and understood their market. Learn how strategic alignment is helping Snoretox progress toward licensing and manufacturing deals that will bring their innovation to market.